Harbour BioMed Enters Agreement to Develop Fully Human Antibody Fragments for Innovative CAR-T Therapy
「Our transgenic mouse platforms for generating fully human monoclonal antibodies have enabled drug discoveries in novel formats such as bi-specific antibodies, as well as conventional antibodies. T......